Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection
about
A new insight into hepatitis C vaccine developmentHepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactVaccination for hepatitis C virus: closing in on an evasive targetAnalysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liverAdaptive immunity in the liverNew immunotherapies targeting the PD-1 pathwayModulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancerSuccess of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cellsTranscriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the NasopharynxStrain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus InfectionRegulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infectionT cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.Stealth and cunning: hepatitis B and hepatitis C viruses.SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell functionA novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine VehicleEffect of hepatitis C virus core protein on the molecular profiling of human B lymphocytesVirus-induced type I IFN stimulates generation of immunoproteasomes at the site of infectionFrequent Recovery and Broad Genotype 2 Diversity Characterize Hepatitis C Virus Infection in Ghana, West AfricaCellular Immune Responses Associated with Occult Hepatitis C Virus Infection of the LiverEvidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus InfectionManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingImpaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV CoinfectionHCV-specific CD27- CD28- memory T cells are depleted in hepatitis C virus and Schistosoma mansoni co-infectionInterferon-gamma is produced by CD8+ T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus lossCellular immune responses against persistent hepatitis C virus: gone but not forgottenEarly impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearanceRelation between viral fitness and immune escape within the hepatitis C virus proteaseLiver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 ExpressionHepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor That Can Suppress HCV-Specific T-Cell ResponsesClearance of low levels of HCV viremia in the absence of a strong adaptive immune responseEx vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersUpregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune DysfunctionViral Sequence Evolution in Acute Hepatitis C Virus InfectionMemory CD8+ T cells are required for protection from persistent hepatitis C virus infectionLimited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL EscapeCD8 Epitope Escape and Reversion in Acute HCV InfectionCellular immune selection with hepatitis C virus persistence in humansImmune evasion versus recovery after acute hepatitis C virus infection from a shared source
P2860
Q21296858-C2B637FB-3040-4BA2-96A8-FEA4C6368EF2Q22299128-42D1B557-923A-4431-A6D1-29271027FC44Q22305922-B44C4E3C-E8AF-4D93-89C9-712D6B8C1D50Q24675828-ADB77CC1-BBEB-4295-B0EE-645BEF0EE9F2Q26753195-0612AB1E-FD67-4083-B1A3-584437C8C62CQ27010018-3F0F0D22-647F-4B9E-B0BF-380AD5FC13DEQ27022761-D9E64C99-71FA-41F1-8C85-073D1E9825BEQ27023059-E18BFFCE-5B17-4056-B88A-D93A00D1F1BEQ27322442-85077E3E-6D0A-4620-B327-EF0EC4346577Q27469607-443C67AD-3016-41A0-8204-5AE20A275143Q27469828-E0E20243-53C3-45DE-AB99-FA689199C3DEQ27469830-FFCFE75A-4FE9-4729-8AEB-527CE3D9D5C9Q27470232-D7B6CFC8-0129-4953-8802-047B68792B8BQ27472767-1477D492-295B-419E-8E02-1DCF5575EFBFQ27472927-E5ADFBF2-5CFD-4581-ACEA-E6F457183489Q27473001-B09E3AD4-30AD-4865-93BB-CE2759AFC1EAQ27473287-D5FF2EDA-82C5-4583-AEF2-DF19C91B918DQ27473390-724BAA49-B060-4CBD-8A43-9D2B6C722B77Q27477499-5E886F11-CD0C-4730-818E-601CCFFED871Q27477557-A0A892DE-FD0D-4D48-925D-6E6150B050BDQ27477613-41735BE0-AC58-45B0-BED4-5F7EBF14C62DQ27477614-72C9828B-5597-4E52-977C-723AB0BE9EC3Q27477626-F07A0AB7-DC29-41DC-A380-FAB9CD4BF202Q27477797-8874F71F-9405-4CC1-BB74-4F50F2387C49Q27478006-498ECA2D-C27C-4B54-957E-C6A37AD62550Q27478124-16D2EF10-38B5-402C-B332-3ECC0708CCA2Q27478326-1BA89414-F2EA-40EF-BA41-3A6C1B3E0F45Q27478328-BB621F2D-FB31-4BEC-A4A3-5797FBA670C0Q27478333-C79937CD-A0F2-462A-9D4F-2CF9D0EF7704Q27478366-28D16F71-C186-454E-BF07-6B018A793EC4Q27480368-35988A32-E85E-47CF-91F9-2D114EC667E6Q27480809-2FD2504A-E58C-47C1-A0F1-4B1EACC2F140Q27480953-B7B97C26-2C7A-47AF-9C12-4C5D675326D2Q27481027-E8B61778-5F67-44C9-9470-F116CCBF6DD4Q27484985-EB64AD43-B213-45E3-9998-D9EEC82D5CB5Q27485119-9B0DF856-26D3-4996-B360-209D5F7068D8Q27485186-B11796D8-44BD-4143-AAF5-73AAC9406E80Q27485189-A76A13B6-7B32-4AD2-9055-257E2FC94BB8Q27485219-992D4061-0699-421F-AD56-21702AFA5727Q27485222-1C0A79BB-AF26-4CAA-AFC5-4DBD395F7AFA
P2860
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Impaired effector function of ...... ic hepatitis C virus infection
@ast
Impaired effector function of ...... ic hepatitis C virus infection
@en
type
label
Impaired effector function of ...... ic hepatitis C virus infection
@ast
Impaired effector function of ...... ic hepatitis C virus infection
@en
prefLabel
Impaired effector function of ...... ic hepatitis C virus infection
@ast
Impaired effector function of ...... ic hepatitis C virus infection
@en
P2093
P3181
P1476
Impaired effector function of ...... ic hepatitis C virus infection
@en
P2093
Greenberg HB
Hoofnagle JH
Nascimbeni M
Rehermann B
Wedemeyer H
P304
P3181
P356
10.4049/JIMMUNOL.169.6.3447
P407
P577
2002-09-15T00:00:00Z